XML 95 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
15. Quarterly Financial Data (Tables)
12 Months Ended
Dec. 31, 2013
Quarterly Financial Data [Abstract]  
Schedule of Quarterly Financial Data [Table Text Block]
As reported:
 
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
2013
 
 
 
 
 
 
 
 
Net sales
 
$
499.7

 
$
525.3

 
$
505.1

 
$
602.6

Gross profit
 
271.4

 
300.1

 
284.2

 
322.7

Net income (loss) attributable to Bio-Rad
 
19.5

 
34.7

 
(7.1
)
 
30.1

Basic earnings (loss) per share
 
$
0.68

 
$
1.22

 
$
(0.25
)
 
$
1.05

Diluted earnings (loss) per share
 
$
0.68

 
$
1.20

 
$
(0.25
)
 
$
1.04

 
 
 
 
 
 
 
 
 
2012
 
 
 
 
 
 
 
 
Net sales
 
$
486.3

 
$
510.4

 
$
498.7

 
$
573.8

Gross profit
 
278.6

 
287.9

 
273.5

 
314.1

Net income attributable to Bio-Rad
 
31.0

 
48.3

 
42.4

 
42.0

Basic earnings per share
 
$
1.10

 
$
1.71

 
$
1.50

 
$
1.48

Diluted earnings per share
 
$
1.09

 
$
1.69

 
$
1.48

 
$
1.46



Adjustments:
 
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
2013
 
 
 
 
 
 
 
 
Net sales
 
$

 
$

 
$

 
$

Gross profit
 

 

 

 

Net income (loss) attributable to Bio-Rad
 
0.7

 
(0.1
)
 

 

Basic earnings (loss) per share
 
$
0.03

 
$
(0.01
)
 
$

 
$

Diluted earnings (loss) per share
 
$
0.02

 
$

 
$

 
$

 
 
 
 
 
 
 
 
 
2012
 
 
 
 
 
 
 
 
Net sales
 
$

 
$

 
$

 
$

Gross profit
 
0.1

 
0.2

 
0.3

 
0.4

Net income attributable to Bio-Rad
 
0.5

 
(0.2
)
 
0.2

 
1.2

Basic earnings per share
 
$
0.02

 
$
(0.01
)
 
$
0.01

 
$
0.04

Diluted earnings per share
 
$
0.01

 
$
(0.01
)
 
$
0.01

 
$
0.05


As revised:
 
First
Quarter
 
Second
Quarter
 
Third
Quarter
 
Fourth
Quarter
2013
 
 
 
 
 
 
 
 
Net sales
 
$
499.7

 
$
525.3

 
$
505.1

 
$
602.6

Gross profit
 
271.4

 
300.1

 
284.2

 
322.7

Net income (loss) attributable to Bio-Rad
 
20.2

 
34.6

 
(7.1
)
 
30.1

Basic earnings (loss) per share
 
$
0.71

 
$
1.21

 
$
(0.25
)
 
$
1.05

Diluted earnings (loss) per share
 
$
0.70

 
$
1.20

 
$
(0.25
)
 
$
1.04

 
 
 
 
 
 
 
 
 
2012
 
 
 
 
 
 
 
 
Net sales
 
$
486.3

 
$
510.4

 
$
498.7

 
$
573.8

Gross profit
 
278.7

 
288.1

 
273.8

 
314.5

Net income attributable to Bio-Rad
 
31.5

 
48.1

 
42.6

 
43.2

Basic earnings per share
 
$
1.12

 
$
1.70

 
$
1.51

 
$
1.52

Diluted earnings per share
 
$
1.10

 
$
1.68

 
$
1.49

 
$
1.51